Get 25% off your first QuanMol agreement—equivalent to 2 months of a medicinal chemist FTE. To redeem, include the correct promo code with your submission below—find it listening to The Biotech Startups Podcast.
QuanMol offers a range of products and services, designed for accelerated molecular design.
QuanMol Thinker:
A revolutionary AI agent that empowers rational molecular design by providing unparalleled insights and decision-making capabilities.
QuanMol Unifier:
A universal molecular representation platform that accurately predicts pharmaceutical properties, streamlining the drug development process.
QuanMol Navigator:
A world-leading structure prediction engine for protein-ligand interactions, providing unparalleled accuracy and efficiency in identifying potential drug targets.
Contact QuanMol to license their product, Redefine.
QuanMol Tech was founded in 2022 by scholars from Caltech, UC Berkeley, and Pinterest, with a goal of boosting early-stage drug discovery by a tenfold increase in speed and efficiency. They have independently developed a new drug design paradigm called “Interaction-Based-Drug-Design,” which leverages AI to understand the definitive interactions between drug candidates and target proteins, overcoming the hurdles of existing drawbacks and improving upon the current generation of drug-design solutions.
QuanMol has collaborated in the development of dozens of assets, spanning disease areas such as oncology, fibrosis, and infectious diseases using all types of structural data (apo, AlphaFold, cocrystal, etc.), drastically reducing this critical first step of small-molecule drug discovery. Additionally, QuanMol has an experienced medicinal chemistry team to help our collaborators with lead optimization to get you to a DC nomination faster.
Are you an Excedr client or a listener of The Biotech Startups Podcast? Unlock exclusive rewards and savings designed to help your business scale and thrive. Fill out the form below to explore partner discounts and benefits tailored to your growth.
